recommend against monitoring with bronchoscopy. There was no published evidence. The panel was not in favor of routine use of bronchoscopy for monitoring but recognized its utility in certain circumstances, such as in the evaluation of infection or alveolar hemorrhage. Suggestions for frequency of monitoring The Voting Panel decided not to provide firm recommendations for frequency of monitoring once an ILD diagnosis is made, but general guidance in the form of suggestions instead. Some patients may need more frequent monitoring, especially if symptoms change, and these suggestions should not be used to inform reimbursement decisions. There is substantial clinical variation from patient to patient that may affect testing frequency. For people with IIM-ILD and SSc-ILD, we suggest PFTs for monitoring every 3 to 6 months for the first year, then less frequently once stable. More frequent monitoring is needed early in the course of disease and in patients with active or progressive